Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

38.18
Delayed Data
As of Aug 07
 -1.57 / -3.95%
Today’s Change
14.16
Today|||52-Week Range
50.49
+22.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Moller San Pedro Claus Juan
Chief Executive Officer
Sale5/14/2020139,154$36.02$5.0M+5.40%
Wedell Wedellsborg Johan Ernst
Director
Sale8/20/2019108,128$27.42$3.0M+39.76%
Sofinnova Ventures Inc
Director
Buy10/30/201990,000$28.00$2.5M+32.32%
Wedell Wedellsborg Johan Ernst
Director
Sale8/29/201989,066$26.58$2.4M+40.59%
Moller San Pedro Claus Juan
Chief Executive Officer
Sale5/13/202060,846$37.75$2.3M+0.45%
Ahmed Mahiuddin
Chief Scientific Officer & Senior Vice President
Sale5/26/202050,000$39.38$2.0M-3.75%
Gad Thomas
Chairman & President
Sale5/12/202050,000$39.04$2.0M-0.18%
Gad Thomas
Chairman & President
Sale5/27/202050,000$39.01$2.0M-2.84%
Wedell Wedellsborg Johan Ernst
Director
Sale8/21/201960,116$27.83$1.7M+36.45%
Kruse Bo
Sale5/14/202037,847$36.03$1.4M+5.40%
Page of 5